The ASX's Next Monster IPO Stock?
Sometimes we have to pinch ourselves…
We're incredibly proud of The Motley Fool's ability to be on the cutting edge of new investing trends…
And our knack for handing our members some incredible stock recommendations, like…
If you had invested in Pro Medicus on in March 2015, when we sent a "buy alert" at $1.48 per share, you would have seen it grow 61% per year. That's an amazing total return of 7,267%.
Or if you had invested in Netflix on 26 July 2012 when we recommended it at $US8.42 per share, you would have seen that investment grow 44% per year. A total return of 7,300%.
Those are past investment recommendations that have been shared with The Motley Fool community over the years – of course not all our picks have done as well – Those recommendations are two of our very best performers. We think you should know not every stock pick goes up… Some go down. And not every stock we've picked has been a winner…
That's why we recommend diversifying and buying several stocks.
And while you can't go back in time and invest in Pro Medicus or Netflix when they were first recommended as a "buy," I believe we're offering you the next best thing…
The chance to get in early on a little-known company we believe could be The ASX's Next Monster IPO Stock.
And while we would never guarantee this new recommendation will produce the returns we've seen from the likes of Pro Medicus or Netflix…
There's just one catch:
We're ONLY sharing the details of this exciting stock with members of The Motley Fool Australia's most ambitious investing service, Motley Fool Extreme Opportunities.
Because we want as many investors as possible to potentially profit from this ASX stock…
Our experts have just published a comprehensive "buy" report inside Extreme Opportunities that shows you exactly why they believe it has so much upside.
This report is FREE to you when you sign up for Extreme Opportunities today.
But you might want to act quickly, given how fast this stock is signing up clients. Simply enter your email address below to access our secure sign-up page.
Returns as of 16 April 2024. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Netflix and Pro Medicus Ltd. The Motley Fool Australia has positions in and has recommended Pro Medicus Ltd. The Motley Fool Australia has recommended Netflix. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. For more information about The Motley Fool see our Financial Services Guide. Please remember that investments can go up and down. Past performance is not necessarily indicative of future returns. Performance figures are not intended to be a forecast and The Motley Fool does not guarantee the performance of, or returns on any investment. Any money back guarantee is strictly limited to the subscription price paid for the product.
